SBC Medical Group

SBC | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.14

+$0.39 (+8.21%)

At close: Sep 21, 2026, 4:00 PM ET

$5.24

+$0.10 (+1.95%)

Pre-market: Sep 22, 2026, 4:43 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Revenue	173.61M	205.42M	193.54M	174.16M
Cost of Revenue	46.32M	49.37M	56.24M	59.33M
Gross Profit	127.28M	156.05M	137.3M	114.83M
Operating Income	67.49M	70.3M	70.66M	20.12M
Interest Income	198.32K	19.94K	86.75K	472.38K
Pretax Income	82.07M	73.46M	73.58M	23.68M
Net Income	50.99M	46.61M	39.37M	6.32M
Selling & General & Admin	58.86M	70.09M	66.23M	93.48M
Research & Development	n/a	n/a	n/a	n/a
Other Expenses	938.7K	15.66M	409.03K	1.23M
Operating Expenses	59.8M	85.75M	66.64M	94.72M
Interest Expense	160.58K	28.3K	45.29K	31.44K
Selling & Marketing Expenses	3.12M	2.78M	n/a	n/a
Cost & Expenses	106.12M	135.11M	122.88M	154.04M
Income Tax Expense	31.02M	26.77M	35.02M	18.12M
Shares Outstanding (Basic)	103M	96.56M	94.19M	15.07M
Shares Outstanding (Diluted)	103M	96.56M	94.19M	15.07M
EPS (Basic)	0.50	0.48	0.42	0.06
EPS (Diluted)	0.50	0.48	0.42	0.06
EBITDA	84.91M	77.28M	85.87M	29.64M
EBIT	82.23M	73.48M	73.62M	23.71M
Depreciation & Amortization	2.68M	3.8M	12.25M	5.93M